Nurix Funding: $120M Raised, Investors & Rounds

Nurix funding overview

Nurix is based in San Francisco. Nurix has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for Nurix runs through 2020; nothing later has been disclosed. Investors on record include Foresite Capital, Bain Capital Life Sciences, Boxer Capital (Tavistock Group), EcoR1 Capital, Redmile Group, Wellington Management Company and 2 others. 8 distinct backers are named across the disclosed rounds.

Nurix at a glance

Total raised: $120M
Latest round date: March 2020
Headquarters: San Francisco
Notable investors: Foresite Capital, Bain Capital Life Sciences, Boxer Capital (Tavistock Group), EcoR1 Capital, Redmile Group, Wellington Management Company, The Column Group, Third Rock Ventures

Frequently asked about Nurix funding

How much has Nurix raised?: Nurix has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Nurix?: Foresite Capital, Bain Capital Life Sciences, Boxer Capital (Tavistock Group), EcoR1 Capital, Redmile Group, Wellington Management Company are named among the investors backing Nurix.
What was the latest Nurix funding round?: No round stage has been disclosed for Nurix.
Where is Nurix based?: Nurix is based in San Francisco.
When did Nurix last raise?: The last disclosed Nurix round closed in March 2020.

Round data for Nurix is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in San Francisco and backer lists below.

Nurix Funding: $120M Raised, Investors & Rounds

Nurix funding overview

Nurix at a glance

Frequently asked about Nurix funding

Companies related to Nurix (36)

Browse related funding lists (9)